171 related articles for article (PubMed ID: 21836531)
1. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Brown JS; Mahmoud TH
Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
[TBL] [Abstract][Full Text] [Related]
2. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents.
Fabinyi DC; O'Neill EC; Connell PP; Clark JB
Clin Exp Ophthalmol; 2011 Dec; 39(9):878-84. PubMed ID: 21631675
[TBL] [Abstract][Full Text] [Related]
3. Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Malik AI; Foster RE; Correa ZM; Petersen MR; Miller DM; Riemann CD
Retina; 2012 May; 32(5):905-11. PubMed ID: 22298013
[TBL] [Abstract][Full Text] [Related]
4. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
Mason JO; Gupta SR; Compton CJ; Frederick PA; Neimkin MG; Hill ML; Heersink MJ; Vail RS; White MF; Feist RM; Thomley ML; Albert MA
Ophthalmology; 2011 Mar; 118(3):543-7. PubMed ID: 20884061
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
7. [Value of different measurements of the preoperative visual acuity and perception of Purkinje's vessel shadows for prediction of the postoperative visual acuity after vitrectomy in diabetic vitreous hemorrhage].
Schulze S; Köhler K; Schüller C
Klin Monbl Augenheilkd; 2006 Apr; 223(4):321-5. PubMed ID: 16639671
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.
Ryan A; Saad T; Kirwan C; Keegan DJ; Acheson RW
Clin Exp Ophthalmol; 2013; 41(4):387-95. PubMed ID: 23094982
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.
Dayani PN; Grand MG
Trans Am Ophthalmol Soc; 2006; 104():149-60. PubMed ID: 17471335
[TBL] [Abstract][Full Text] [Related]
11. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy.
Soto-Pedre E; Hernaez-Ortega MC; Vazquez JA
Ophthalmic Epidemiol; 2005 Oct; 12(5):335-41. PubMed ID: 16272053
[TBL] [Abstract][Full Text] [Related]
13. Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage.
Kuhn F; Morris R; Witherspoon CD; Mester V
Ophthalmology; 1998 Mar; 105(3):472-7. PubMed ID: 9499778
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
15. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
16. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet and anticoagulation therapy in vitreoretinal surgery.
Oh J; Smiddy WE; Kim SS
Am J Ophthalmol; 2011 Jun; 151(6):934-939.e3. PubMed ID: 21411057
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Hartley KL; Smiddy WE; Flynn HW; Murray TG
Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
Jirawison C; Ittipunkul N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
[TBL] [Abstract][Full Text] [Related]
20. Short-term outcomes of 23-gauge pars plana vitrectomy.
Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
